Listar por Autor Couto, Marcos
Mostrando resultados 1 a 8 de 8
| Fecha de publicación | Título | Autor(es) |
| 2024 | Advancements in the synthesis and biological properties of carboranes and high‑boron related compounds: a comprehensive exploration with emphasis on BNCT applications | Couto, Marcos; Cerecetto, Hugo |
| 2020 | Closo-carboranyl- and metallacarboranyl [1,2,3]triazolyl-decorated lapatinib-scaffold for cancer therapy combining tyrosine kinase inhibition and boron neutron capture therapy | Couto, Marcos; Alamón, Catalina; García Melián, María Fernanda; Kovacs, Mariángeles; Trias, Emiliano; Nievas, S.; Pozzi, E.; Curotto, P.; Thorp, S.; Dagrosa, M. A.; Teixidor, Francesc; Viñas, Clara; Cerecetto, Hugo |
| 2013 | Diseño, síntesis y evaluación biológica de compuestos híbridos ditioltiona-flavonoide como potenciales agentes inductores de Quinona reductasa y Glutatión S-transferasa en quimioprevención del cáncer | Couto, Marcos |
| 2019 | Diseño, síntesis y evaluación biológica de nuevos organoboranos con uso en terapia antitumoral de glioblastoma por captura neutrónica de boro (10B) | Couto, Marcos |
| 2025 | Escaping from flatland: 3D carborane-based bioisosteres of Erlotinib as potential anticancer agents | Dávila Saralegui, Belén; Vignolo, Pablo; González Alayón, Ignacio Darwin; Lecot Calandria, Nicole Valerie; Bonanata, Jenner; García, María Fernanda; Echeverría, Gonzalo A.; Piro, Oscar E.; Cerecetto, Hugo; Couto, Marcos |
| 2025 | Novel potential drug scaffold against visceral Leishmaniasis discovered using a drug repurposing approach | Ramos, Rachel; Álvarez, Guzmán; Couto, Marcos; Comini, Marcelo A.; Benítez, Diego; Aguilera, Elena |
| 2025 | Structure-activity relationships of closo- and nido-carborane Erlotinib analogs: lipophilicity as a key modulator of anti-glioma activity | Dávila Saralegui, Belén; Vignolo, Pablo; Silvarrey, Martina; Benitez, Andrés; González Schmidt, Juliana; de Arteaga Guidotti, Carmela; García, María Fernanda; Cerecetto, Hugo; Couto, Marcos |
| 2020 | Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity | Alamón, Catalina; Dávila Saralegui, Belén; García Melián, María Fernanda; Sánchez, Carina; Kovacs, Mariángeles; Trias, Emiliano; Barbeito, Luis; Gabay, Martín; Zeineh, Nidal; Gavish, Moshe; Teixidor, Francesc; Viñas, Clara; Couto, Marcos; Cerecetto, Hugo |